Form 4: Quest Diagnostics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 242 shares of common stock to cover tax withholding obligations arising from the vesting of restricted stock units.
Summary
- On February 19, 2025, Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 242 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $169.71.
- Following the transaction, Delaney directly owns 6,197 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, which is neutral in sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of transaction: Mark E. Delaney disposed of shares to cover tax obligations. |
| 02/21/2025 | Date of signature: Sean D. Mersten, Attorney in Fact for Mark E. Delaney, signed the Form 4. |
Keywords
Quest Diagnostics, Mark E. Delaney, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, DGX, SVP, Chief Commercial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.